The first doses of the vaccine could arrive in Italy in April Johnson&Johnson, as soon as Ema, the European regulatory authority and Aifa, the Italian agency, have the ok. This was said by the president of Farmindustria Massimo Scaccabarozzi at “Half an hour more” by Lucia Annunziata, on Raitre. By June, he added, a few million doses could arrive in Italy and 27 million by December.
<!– #correlati article figure .player_clicker::after { color: #fff; background-color: rgba(0,0,0,0.6); border-radius: 50%; display: block; text-align: center; font-size: 16px; line-height: 40px; width: 40px; position: absolute; top: 50%; left: 50%; margin: -20px 0 0 -21px; } #correlati article figure .player_foto_clicker::after { color: #fff; background-color: rgba(0,0,0,0.6); border-radius: 50%; display: block; text-align: center; font-size: 20px; line-height: 40px; width: 40px; position: absolute; top: 50%; left: 50%; margin: -20px 0 0 -21px; }–>
For Scaccabarozzi, Johnson & Johnson’s single-dose vaccine is an «extra vaccine. We must have several – he pointed out – because there is an important question ». With the European Commission “there is a pre-emption agreement for 200 million doses until the end of the year and, of these, 27 million are for Italy. We plan to deliver some doses in the second quarter from April. But the big one will happen in the second half ».
The Johnson & Johnson vaccine, he continued, “works with a single dose, does not need booster” and “does not require large cold chains, because it can be stored in a common refrigerator.” As for Italy’s ability to produce vaccines, the president of Farmindustria said that “at the end of the year we could imagine having an Italian production, or at least a participation in production also on the Italian side, because this has already been a scientific collaboration race. in world research “.
“We are working together with Minister Giorgetti to find the companies that produce the vaccine”. With the Mise therefore, «with which it was agreed to meet once a week» a real «scanning on the companies that want to modify the infialatori» is being carried out. About 100 companies around the world have been monitored, he adds, but, he continues, “what is important is that industry and government want to collaborate for the production of vaccines in Italy and Europe”.
Last updated: 17:14
© REPRODUCTION RESERVED – below) // the var will be used by PaywallMeter to target the event on the correct pixel settings_testata.fbq_swg_promo = ‘556738118336305’; fbq (‘init’, header_settings.fbq_swg_promo); fbq (‘track’, ‘PageView’);
.
